The Cruciform Building,
Division of Surgery & Interventional Science,
University College London,
London WC1E 6BT.
- Dr. Rifat Hamoudi, PhD is a multidisciplinary researcher.
- He started out as electronic engineer but moved into medical sciences.
- He has BSc in Biology and Chemistry, Three different MSc degrees from University of London in Engineering, Computer Science and Biochemistry and a PhD from Cambridge University in Molecular Medicine and Pathology.
- He worked in cancer genetics at the Royal Marsden Hospital and Institute of Cancer Research isolating and characterising many cancer causing genes and was a member of the team that discovered BRCA2.
- Following the publishing of the human genome in 2001 he moved to work in molecular pathology establishing and applying novel wet methodologies, algorithms and software for molecular screening and personalised medicine, diagnostic and prognostic biomarker discoveries and understanding the molecular mechanism of various diseases with a view to identifying key therapeutic targets.
- More recently, he has used therapeutic targets in photo and sonodynamic therapy to address the problems of heterogeneity and clonal evolution in treating urological disease.
- He is also the lead in software and algorithms development and has written many information management system software using various software engineering methodologies to collate, store clinicopathology information and correlate that to genomics data.
- Dr. Hamoudi is a Fellow of the Institute of Biomedical Sciences, Biological Society, British Computer Society, Institute of Physics and Engineering in Medicine.
- He has Chartered Engineer and European Engineer status.
- He has more than 100 publications in high impact journals including PNAS, Nature, Nature Genetics, Science and Cell in areas including bioinformatics, cancer genetics and molecular pathology.
- He is in the editorial board of the Journal of Clinical and Medical Imaging and Journal of Translational Oncogenomics.
- Currently, he is Associate Professor in Computational & Molecular Pathology and Group Leader in Advanced Targeted Therapeutics at the Research Department of Tissue and Energy within the Division of Surgery & Interventional Sciences at University College London.